Sodium nitrate protects against metabolic syndrome by sialin-mediated macrophage rebalance
8.0
来源：
Nature
关键字：
ML brain science
发布时间：
2025-10-02 11:32
摘要：
Sodium nitrate (NaNO3) has been shown to effectively mitigate metabolic syndrome, particularly in mouse models of metabolic dysfunction. The study reveals that NaNO3 operates through a novel mechanism involving the sialin-mediated rebalancing of macrophages, which plays a crucial role in modulating inflammatory responses. This research highlights the potential of NaNO3 as a therapeutic agent for managing metabolic disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM).
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分
business_impact
0.5分+0.5分
scientific_rigor
1.5分+1.5分
timeliness_innovation
1.5分+1.5分
investment_perspective
2.5分+2.5分
market_value_relevance
1.0分+1.0分
team_institution_background
0.5分+0.5分
technical_barrier_competition
1.0分+1.0分
关键证据
NaNO3 significantly lowers plasma transaminase levels and mitigates severe hepatic inflammation.
Sialin is integral to the regulatory process of macrophages by NaNO3.
The study provides a novel mechanism involving the sialin-CtsL-Nrf2 axis.
真实性检查
否
AI评分总结
Sodium nitrate (NaNO3) has been shown to effectively mitigate metabolic syndrome, particularly in mouse models of metabolic dysfunction. The study reveals that NaNO3 operates through a novel mechanism involving the sialin-mediated rebalancing of macrophages, which plays a crucial role in modulating inflammatory responses. This research highlights the potential of NaNO3 as a therapeutic agent for managing metabolic disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM).